Unlocking the access to rare plant-based therapeutic
compounds through biotechnology
STH BIOTECH, A PLANT BIOTECH PIONEER
A UNIQUE PRODUCTION PLATFORM
Fueling pharmaceutical innovation, SATIVITRO® can deliver reliable and pure APIs to empower companies in their quest for breakthrough medicines.
SATIVITRO®
Bioproduction
YOUR MOLECULE FOR YOUR APPLICATION
SEEKING TO TRY NEW DRUGS CANDIDATES ?
SOLVING ACCESSIBILITY CHALLENGE
Unlocking new solutions, we break through the barriers of limited access to plant-based compounds, revolutionizing yields by amplifying the plant's metabolism for a 1000-fold increase in target compounds.
OUR CURRENT FOCUS
Cannabis is a gold mine of therapeutic compounds, with cannabinoids serving as promising treatments to address chronic pain, mental disorders, and neurodegenerative diseases.
Interest directed towards the exploration of minor cannabinoids and alkaloids.
AN INNOVATIVE SOLUTION
Embracing the future, STH BIOTECH is committed to ensure that our technology drives a transformative influence on both society and the environment.
SCALABLE
SUSTAINABLE
COST-EFFICIENT
CONSISTENT
@Genopole
SUPPORTED BY
Grand Prix 2023